Research roundup

Debbie Rigby takes a look at the latest in research news Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis A US position statement on the prevalence of SGLT-2–associated DKA suggests that DKA occurs infrequently and that the risk-benefit ratio overwhelmingly favors continued use of SGLT-2 inhibitors with no changes in current recommendations. However the authors highlight